Evidence map›Paper›PMID 41224105›Full record

ArticleJournal of the National Cancer Institute2026

Disparities in cancer survival by socioeconomic status: findings from a population-based study of 942 241 Australians from 1980 to 2019.

Sarsha Yap, Qingwei Luo, Jeff Cuff, David Goldsbury, Xue Qin Yu, Yoon-Jung Kang, Benjamin D T Gallagher, Eleonora Feletto, Marianne Weber, Preston Ngo and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sarsha YapThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0002-2049-6352
Qingwei LuoThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0002-8902-6869
Jeff CuffFaculty of Science Biotech and Biomolecular Science, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0009-0009-4670-1842
David GoldsburyThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0001-6247-2706
Xue Qin YuThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0001-8638-7979
Yoon-Jung KangThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0003-4045-1941
Benjamin D T GallagherThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.
Eleonora FelettoThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0001-6192-4694
Marianne WeberThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0001-5731-9651
Preston NgoCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0001-5453-0734
Melissa A MerrittThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.
Karen CanfellSchool of Public Health, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-6443-6618
David P SmithThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0002-1474-3214
Julia SteinbergThe Daffodil Centre, The University of Sydney, and Cancer Council NSW, Sydney, New South Wales, Australia.ORCID 0000-0002-0585-2312

Funding

Cancer Institute NSW Career Development Fellowship 2022/CDF1154Cancer-Patient Population Projections project MRF1200535National Health and Medical Research Council of Australia APP1194679World Health Organization 001
6 · The paper itself

Abstract

Cancer survival in Australia has improved over time, but disparities by socioeconomic status persist. We analyzed data from the population-wide New South Wales Cancer Registry, including 942 241 individuals with invasive solid cancers diagnosed between 1980 and 2019. We examined cancer-specific and all-cause deaths by area-based socioeconomic status for all solid cancers and 12 common cancers using competing risks regression alongside crude survival. Five-year cancer-specific survival for all cancers improved from 50.3% in 1980-1989 to 73.3% in 2010-2019. Risk of cancer death was higher for individuals living in most socioeconomically disadvantaged areas (vs least disadvantaged areas), and differences increased over time: from a sub-hazard ratio of 1.04 (95% CI = 1.02 to 1.07) in 1980-1989 to 1.35 (95% CI = 1.32 to 1.38) in 2010-2019 (adjusting for age, sex, cancer type, cancer spread). Statistically significant and increasing differences were observed for prostate, breast, melanoma, colorectal, lung, bladder, and stomach cancers. Disparities in cancer survival have continued to widen, requiring improved understanding and targeted interventions to address inequities.

Indexed as

Health Status DisparitiesNeoplasmsSocial ClassAdultAgedAged, 80 and overAustralasian PeopleAustraliaFemaleHumansLow Socioeconomic StatusMaleMiddle AgedNew South WalesRegistriesSocioeconomic Disparities in Health

Identifiers

PMID41224105
PMCPMC13339099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.